Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study.
Takao OgawaKoji MatsumotoIchiro TojimaHirotaka KikuokaDaiki HiraTakeshi ShimizuPublished in: The Annals of otology, rhinology, and laryngology (2022)
VPA seems to be a safe treatment option in patients with PVOD. The effects of VPA treatment for PVOD patients should be studied with a controlled study design in the future.